Paul Young

Paul Young is a highly experienced leader in the pharmaceutical and academic sectors. Currently serving as Chief Executive Officer of Ab Initio Pharma since February 2021, Paul heads a company specializing in pharmaceutical formulation R&D and manufacturing in Sydney, Australia. Concurrently, Paul holds the position of Professor of Commercialisation at Macquarie University and serves as Director of OzUK, a pharmaceutical contract services firm focused on liquid-based therapeutics. Paul also leads respiratory technology initiatives as Head of Respiratory Technology and serves as Deputy Executive Director at Woolcock Institute of Medical Research. Prior experience includes various roles at the University of Sydney, culminating as Chair of Commercialisation, and a postdoctoral fellowship at the University of Bath, where Paul earned a PhD in Pharmaceutics.